Headquarters
San Jose, CA
Industry
Life Sciences – Biotechnology – Cosmetic
Overview
VNUS Medical develops and commercializes products for minimally invasive treatment of venous disease.
Solution
QAD Enterprise Applications was implemented to help VNUS keep up with rapid growth.
Results
While using QAD and Strategic VNUS revenue grew from M to 101M. VNUS was acquired by Covidien in 2009 for $440 million.
